Collaboration to Transition Members to Preferred Formulary Dipeptidyl-Peptidase-4 Inhibitor
ABSTRACT Objective: To describe the outcomes of a partnership between a drug plan and pharmacists to switch patients from brand name dipeptidyl-peptidase-4 inhibitors to the generic alogliptin. Study Design: Single-center, retrospective chart review. …